AU2001236905A1 - Bioadhesive composition - Google Patents

Bioadhesive composition

Info

Publication number
AU2001236905A1
AU2001236905A1 AU2001236905A AU3690501A AU2001236905A1 AU 2001236905 A1 AU2001236905 A1 AU 2001236905A1 AU 2001236905 A AU2001236905 A AU 2001236905A AU 3690501 A AU3690501 A AU 3690501A AU 2001236905 A1 AU2001236905 A1 AU 2001236905A1
Authority
AU
Australia
Prior art keywords
bioadhesive composition
solid
solution
polymer mixture
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001236905A
Inventor
Dieter Ameye
Catherine Callens
Paul B. Foreman
Jean-Paul Remon
Paul Richardson
John Tsai
Jody Voorspoels
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Starch and Chemical Investment Holding Corp
Original Assignee
National Starch and Chemical Investment Holding Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Starch and Chemical Investment Holding Corp filed Critical National Starch and Chemical Investment Holding Corp
Publication of AU2001236905A1 publication Critical patent/AU2001236905A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/246—Intercrosslinking of at least two polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2300/00—Characterised by the use of unspecified polymers
    • C08J2300/10—Polymers characterised by the presence of specified groups, e.g. terminal or pendant functional groups
    • C08J2300/104—Polymers characterised by the presence of specified groups, e.g. terminal or pendant functional groups containing oxygen atoms

Abstract

This invention relates to a method of producing a bioadhesive composition comprising the steps of preparing a solution of a solvent and a polymer mixture wherein the polymer mixture comprises at least one natural or synthetic polycarboxylated polymer and at least one polysaccharide; drying the solution to form a solid; and heat treating the solid to effect cross-linking and to form the bioadhesive composition.
AU2001236905A 2000-02-11 2001-02-08 Bioadhesive composition Abandoned AU2001236905A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/502,585 US6284235B1 (en) 2000-02-11 2000-02-11 Bioadhesive composition
US09502585 2000-02-11
PCT/US2001/004418 WO2001058430A1 (en) 2000-02-11 2001-02-08 Bioadhesive composition

Publications (1)

Publication Number Publication Date
AU2001236905A1 true AU2001236905A1 (en) 2001-08-20

Family

ID=23998471

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001236905A Abandoned AU2001236905A1 (en) 2000-02-11 2001-02-08 Bioadhesive composition

Country Status (6)

Country Link
US (2) US6284235B1 (en)
EP (1) EP1257258B1 (en)
AT (1) ATE428406T1 (en)
AU (1) AU2001236905A1 (en)
DE (1) DE60138362D1 (en)
WO (1) WO2001058430A1 (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284235B1 (en) * 2000-02-11 2001-09-04 National Starch And Chemical Company Investment Holding Corporation Bioadhesive composition
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
DE60231510D1 (en) * 2001-08-01 2009-04-23 Novartis Ag COMPOSITION FOR MASKING THE TASTE
US7846478B2 (en) 2002-01-31 2010-12-07 Henkel Ag & Co. Kgaa Bioadhesive composition
WO2005009364A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2006528189A (en) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション Antibiotic products, their use and formulation
WO2005009368A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1653925A1 (en) 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robust pellet
CA2535398C (en) 2003-08-12 2013-11-12 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
US8246996B2 (en) 2003-08-29 2012-08-21 Shionogi Inc. Antibiotic product, use and formulation thereof
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
DE10358748A1 (en) 2003-12-12 2005-07-14 Lts Lohmann Therapie-Systeme Ag Dosage form based on crosslinked hydrophilic polymers
US20050249799A1 (en) * 2004-03-03 2005-11-10 Spherics, Inc. Polymeric drug delivery system for hydrophobic drugs
US20050276771A1 (en) * 2004-06-10 2005-12-15 Lewis Farsedakis Color-giving lip covering, color for lips, peelable cosmetics, and other cosmetics
WO2006014427A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
EP1796747B1 (en) 2004-08-27 2017-07-05 Antonio Lauto Bioadhesve film for tissue repair
US20070281007A1 (en) * 2004-08-27 2007-12-06 Jacob Jules S Mucoadhesive Oral Formulations of High Permeability, High Solubility Drugs
US20060045865A1 (en) * 2004-08-27 2006-03-02 Spherics, Inc. Controlled regional oral delivery
EP1846505B1 (en) * 2005-02-09 2015-11-11 Covidien LP Synthetic sealants
US20070026052A1 (en) * 2005-07-28 2007-02-01 Baggett Richard W Hemostatic material
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US20070190013A1 (en) * 2006-02-13 2007-08-16 Yeli Zhang Film and film-forming compositions
WO2007127172A2 (en) * 2006-04-27 2007-11-08 The Trustees Of Columbia University In The City Of New York Layered bio-adhesive compositions and uses thereof
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2009048929A1 (en) 2007-10-08 2009-04-16 Lux Biosciences, Inc. Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors
MX338355B (en) 2009-06-09 2016-04-13 Aurinia Pharmaceuticals Inc Topical drug delivery systems for ophthalmic use.
WO2011026111A1 (en) 2009-08-31 2011-03-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Oral delivery of a vaccine to the large intestine to induce mucosal immunity
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US10085938B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for preventing sore throat in humans
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US20130202675A1 (en) 2012-02-03 2013-08-08 Dynasil Biomedical Corporation Systems and methods for the fabrication of tissue patches
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
DE102014012238A1 (en) 2014-08-21 2016-02-25 Johns Manville Europe Gmbh Binder-solidified textile fabric, process for its production and its use
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
AU2016307447A1 (en) 2015-08-07 2018-02-22 Xcede Technologies, Inc. Adhesive compositions and related methods
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
BR112021024271A2 (en) 2019-06-14 2022-01-11 Procter & Gamble Compositions for rinse-free oral care
EP3982912A1 (en) 2019-06-14 2022-04-20 The Procter & Gamble Company Leave-on oral care compositions
WO2020248232A1 (en) * 2019-06-14 2020-12-17 The Procter & Gamble Company Leave-on oral care compositions
JP7288090B2 (en) 2019-06-14 2023-06-06 ザ プロクター アンド ギャンブル カンパニー Leave-in oral care composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
CA2018471A1 (en) * 1989-07-28 1991-01-28 Ian W. Kellaway Mucoadhesive hydrogels delivery system
ES2134769T3 (en) * 1989-10-31 1999-10-16 Columbia Lab Bermuda Ltd TISSUE HUMIDIFICATION PROCEDURE AND COMPOSITION.
EP0451433B1 (en) * 1990-04-12 1996-10-23 Janssen Pharmaceutica N.V. Composition of a bioadhesive sustained delivery carrier for drug administration
US5942253A (en) * 1995-10-12 1999-08-24 Immunex Corporation Prolonged release of GM-CSF
WO1998022097A2 (en) * 1996-11-20 1998-05-28 Bio Advances, Llc Controlled release matrix composition using polar polymer or monomer and poly(acrylic acid) blend
US5840329A (en) * 1997-05-15 1998-11-24 Bioadvances Llc Pulsatile drug delivery system
US5895804A (en) 1997-10-27 1999-04-20 National Starch And Chemical Investment Holding Corporation Thermosetting polysaccharides
WO2000047644A1 (en) 1999-02-12 2000-08-17 Universiteit Gent A biocompatible adhesive system and a bioadhesive drug delivery system with controllable release
US6284235B1 (en) * 2000-02-11 2001-09-04 National Starch And Chemical Company Investment Holding Corporation Bioadhesive composition

Also Published As

Publication number Publication date
US20020028241A1 (en) 2002-03-07
US6824792B2 (en) 2004-11-30
DE60138362D1 (en) 2009-05-28
EP1257258B1 (en) 2009-04-15
WO2001058430A1 (en) 2001-08-16
EP1257258A1 (en) 2002-11-20
ATE428406T1 (en) 2009-05-15
US6284235B1 (en) 2001-09-04

Similar Documents

Publication Publication Date Title
AU2001236905A1 (en) Bioadhesive composition
DE60219319D1 (en) DRY HEMOSTATIC COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
AU6198700A (en) Process for producing phenyl-alkanes compositions produced therefrom, and uses thereof
AU6358594A (en) Macromolecular microparticles and methods of production
GB2368585A (en) Compositions and processes for oil field applications
WO1995009821A3 (en) Improved cement admixture product having improved rheological properties and process of forming same
AU1469201A (en) Hyperbranched polyol macromolecule, method of making same, and coating composition including same
AU5126199A (en) Partially saponified triglycerides, their methods of manufacture and use as polymer additives
EP0905289A3 (en) Antibacterial cellulose fiber and production process thereof
WO2003007839A3 (en) Devices form naturally occurring biologically derived
ATE245219T1 (en) METHOD FOR PRODUCING CONDITIONING TOWELS
AU4362197A (en) Compositions and methods for selectively cross-linking films and improved film articles resulting therefrom
AU2001263030A1 (en) Coating apparatus and methods of applying a polymer coating
ID27377A (en) NEW FORM OF IRBESARTAN, THE PROCESS OF MAKING IT AND THE PHARMACY COMPOSITION THAT CONTAINS THE IRBESARTAN
TW268031B (en)
CA2346946A1 (en) Compositions and methods for preparing dispersions and methods for using the dispersions
ATE323118T1 (en) METHOD FOR PRODUCING POLYARYLENE VINYLENE DERIVATIVES
HUP0004403A3 (en) Process for the production of heterophasic polymer compositions, and compositions thus obtained
AU9313198A (en) Gas generant compositions, methods of production of the same and devices made therefrom
WO2002041827A3 (en) Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
NO305441B1 (en) Use of G-block polysaccharides
CA2400300A1 (en) Method for producing shredded tobacco and production system for use therein
CA2135226A1 (en) Process for Treating Oil-Bearing Formation
SG90225A1 (en) Polymer compound, method of producing the same, photosensitive composition, and pattern formation method
TW354451B (en) Method of fabricating cross-linked biobased materials and structures fabricated therewith a method comprising the step of: forming the mixture of polymer and cross-linked agent